4,912 Shares in Chemed Co. (NYSE:CHE) Acquired by Caisse DE Depot ET Placement DU Quebec

Caisse DE Depot ET Placement DU Quebec purchased a new stake in shares of Chemed Co. (NYSE:CHE - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 4,912 shares of the company's stock, valued at approximately $2,952,000.

Other large investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its stake in shares of Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company's stock valued at $47,000 after purchasing an additional 22 shares during the last quarter. American National Bank & Trust purchased a new stake in Chemed in the 3rd quarter valued at about $61,000. Mather Group LLC. lifted its position in Chemed by 60.5% in the second quarter. Mather Group LLC. now owns 183 shares of the company's stock valued at $99,000 after buying an additional 69 shares during the last quarter. Quarry LP boosted its stake in Chemed by 721.7% during the second quarter. Quarry LP now owns 189 shares of the company's stock worth $103,000 after buying an additional 166 shares during the period. Finally, Sound Income Strategies LLC acquired a new stake in shares of Chemed during the third quarter valued at about $201,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Performance

Shares of CHE traded up $0.83 during mid-day trading on Tuesday, hitting $567.26. 73,746 shares of the company's stock were exchanged, compared to its average volume of 86,034. The company has a market cap of $8.54 billion, a price-to-earnings ratio of 28.66, a P/E/G ratio of 2.40 and a beta of 0.46. The stock's 50-day moving average is $577.81 and its 200-day moving average is $565.04. Chemed Co. has a fifty-two week low of $523.33 and a fifty-two week high of $654.62.

Chemed (NYSE:CHE - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). The business had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. Chemed's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the company earned $5.32 earnings per share. As a group, equities research analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Monday, November 18th. Chemed's dividend payout ratio is currently 10.11%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on CHE shares. Royal Bank of Canada lowered their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Saturday.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. The trade was a 1.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director George J. Walsh III sold 400 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the transaction, the director now directly owns 3,046 shares in the company, valued at $1,819,893.62. This trade represents a 11.61 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,845 shares of company stock worth $3,978,798. 3.32% of the stock is currently owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.